Catalyst Wire Dossier Catalyst Wire Dossier

rAd-p53 gene therapy

· Shenzhen SiBiono GeneTech Co.,Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAd-p53 gene therapy, covering 2012-04-09 to 2012-04-09. Get the full timeline:

Most recent: Clinical Trial Update: rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors [Phase 4]

See pricing